¡°	anti incontinence drug oxybutynin	3.8780624438402236
¡°	sustain release oxybutynin formulation	3.3523822714545317
	Ditropan XL	3.0563985596816767
¡°	daily control release oxybutynin formulation	2.240955667108102
	urinary incontinence drug	1.9972226715169408
	urge incontinence	1.8182228859035183
	argument	1.3738833959523158
	gastrointestinal GI tract	1.0048991854442006
	vitro dissolution apparatus	0.8709085671808936
	Oxybutynin	0.7248813899720925
	Fridolph	0.7248813899720925
	absorption	0.5889825275438308
	small intestine	0.2920864619922211
	articulation	0.2914754498028541
	Kahn bear	0.2736720328163405
	sustained extend release	0.2573183054770113
	anda formulation	0.21562071667461508
	immediate release	0.21429269407192306
	non arbitrary decisionmaking	0.21149620432632363
	ï¿½ï¿½	0.20177355956472565
	Medichem	0.17874477707997216
	Rolabo	0.17874477707997216
	pharmacology	0.17564456025424058
	steady dosing	0.1649286910993284
	extend release version	0.1568449131285444
	S.L.	0.15631733358585553
	Gartside	0.14581019526289316
	conjecture	0.14416317753248695
	hour	0.1430323621350761
	statutorily proscribe hindsight reasoning	0.13561010794608871
	Dembiczak	0.12102351952925301
	dissolve drug	0.12071920571313975
¡°	day extended release formulation	0.11783893398141346
	Dosage form	0.11044978213980719
	Impax filing	0.10227773339433328
	unremarkable premise	0.09930541916463222
	West Virginia	0.09435895273024929
	orally administer drug	0.09416403449634737
	different dosage	0.09256161800415681
	Owner	0.08941064727263102
	mg	0.08477292943603609
	convenience	0.07819212513040275
	mere speculation	0.07418165417037136
	rate	0.07251361140640142
	Cross Medical Products	0.07239724342086411
	Kotzab	0.07215405912770956
	anti hindsight jurisprudence	0.06889092281971648
	dosage form	0.061710860813843915
	flexibility	0.06131282702174982
	Wang	0.054837456678644425
	DISCUSSION	0.04455472792801163
	therapeutic dose	0.04010119663982051
	Administrative Procedure Act	0.038168911707620455
	bright line rule	0.03690935307893352
	Medtronic Sofamor Danek Inc.	0.03609228907442544
	day dosing	0.035760666602452904
	rational underpinning	0.03529271833234382
	Supreme Court obviousness jurisprudence	0.031009044325309945
	Franklin Sports Inc.	0.030955632491673966
	Gajarsa	0.030819957197568332
	ingredient	0.03036029416669732
	body tissue	0.02587680844423076
	implicit factor	0.02251145079258481
	two Abbreviated New Drug Applications	0.022212107097149845
	usual benefit	0.021008107135765022
	pharmaceutically acceptable salt	0.017844504129128292
	ANDA product	0.01683381440830882
	pure question	0.016437583657342276
	reasonable expectation	0.01607290982963714
	oral administration	0.016060253558009094
	implicit showing	0.014673600784786515
	non hindsight drive conclusion	0.01416155356846642
	brief orientation	0.012617134090675138
	rigid test	0.012349445019486946
	S.A.	0.011489051309189003
	core	0.01031948345345864
	i. BACKGROUND	0.00939886312953344
	noninfringement	0.008983325745675657
	practical test	0.007438311035372675
	recent decision	0.0074243351493846034
	Markman Order	0.007200114774705147
	generic version	0.0066921335521626405
	Opinion	0.006440807691042568
	nonobviousness	0.0056734858953557
	motivation suggestion teach test	0.005250561109885965
	success	0.004864895821841453
	theory	0.0048612404227392604
	articulate reasoning	0.004757481782166129
	anticipation	0.0043672299798500035
	Board determination	0.004359417490470628
	definite firm conviction	0.003908715923745326
	mere conclusory statement	0.0038220754353818606
	proof	0.0038024154389432723
	secondary consideration	0.003789680523644255
	Federal Circuit predecessor motivation	0.0037561604225653093
	motivation suggest teaching test	0.0036079698544716587
	generic product	0.0034355525777788817
	motivation suggest teaching requirement protect	0.0033639500034417947
	II	0.003286980458608996
	analogous art test	0.0029619960259934376
	current state	0.0025578772201779554
	several basic factual inquiry	0.0024281710543100255
	internal quotation	0.002410984470813763
	approach	0.002202852445545534
	Obviousness	0.001990909351734939
	treatment	0.001799740316756345
	Prods	0.0017216186663809897
	combine teaching	0.0017099253383164915
	obviousness statute	0.0016686092786484443
	actual teaching	0.0015796738986446589
	Northern District	0.0015337948050035098
	bench trial	0.0014750577201382367
	statutory presumption	0.0014680410026840576
	knowledge	0.0014546827449069496
	content	0.0012142166703476547
	propose manufacturer	0.0010830075957712815
	explanation	0.0009499449239017783
	absence	0.0009411448385739147
	pertinent art aspect	0.0008737389215891719
	rejection	0.0008090378191668929
	burden	0.000785218634475519
	multiple reference	0.000701908485675731
	general problem	0.0006188061481466268
	discussion	0.0004950989455686849
	obviousness inquiry	0.0004936720152613883
	relevant prior art teaching	0.00041673279037259903
	owner	0.0003852137385294832
	obviousness ground	0.00033655088462949674
	practice	0.0003310213337751485
	underlie factual inquiry	0.00033013142375812354
	obviousness law	0.00032439363681335327
	PTO obviousness finding	0.0003133493995327069
	patentability	0.0002841044577271728
	obviousness analysis	0.0002254581810238579
	citation	0.00021949961766547067
	obviousness determination	0.00021900652746594697
	litigation	0.0002130530435313132
	level	0.00021180026916972663
	side effect	0.0002113034187876962
	invalidity	0.00019294348701042117
	underlie factual question	0.0001820613638290946
	objective evidence	0.00017979380796116678
	ordinary skill	0.00017864300260496708
	background	0.00013904353916222912
	turn	0.00010985516672553446
	holding	0.000107149300630947
	legal determination	0.00010146632484148494
	due process	7.444936373937849e-05
	legal conclusion	6.781662731465565e-05
	combination	5.827246907126243e-05
	district court ruling	5.209025482271282e-05
	two type	4.9141884482990825e-05
	give portion	4.496436620916494e-05
	addition	3.806932376225742e-05
	de novo	3.6462575391262364e-05
	emphasis	2.985520916481832e-05
	jurisdiction	2.9496944056049562e-05
	favor	1.9750638188602898e-05
	clear error standard	1.906775425150774e-05
	difference	1.662275128140388e-05
	need	1.2420046399402917e-05
	direct evidence	9.660191458546446e-06
	court view	8.781274310613159e-06
	court analysis	6.9176812067408265e-06
	inventor	5.66922734391391e-06
	Idaho	2.2581700331519156e-06
	subject matter	1.9900536862106107e-06
	scope	1.5546510747346337e-06
	one reference	1.151293660378599e-06
	prior art reference	8.582973331775537e-07
	assert	7.583289146246802e-07
	light	5.975289469569875e-07
	review	3.54983946297235e-08
	use	5.980861852114056e-09
	district court judgment	3.91114318422941e-09
	invention	3.418799842595598e-09
	Appeals	0.0
